| Dr Micah Marshall Likness, MD | |
|
2525 Fox Run Parkway, Suite 101, Yankton, SD 57078-5371 | |
| (605) 665-0062 | |
| (605) 665-0076 |
| Full Name | Dr Micah Marshall Likness |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 2525 Fox Run Parkway, Yankton, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124269162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 8836 (South Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Ear, Nose And Throat Associates P C | 8729990940 | 16 |
News Archive
The epic of health care evolution is complex and is worth reviewing over the last five decades. Having practiced medicine in the same community in Southeast Missouri for more than 30 years, I have seen changes in health care beyond the scope of imagination (Dr. S.D. Madduri, 2/18).
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
The Translational Genomics Research Institute (TGen) will host Pediatric Cancer Translational Genomics Feb. 6-8 at the Hotel Valley Ho in Scottsdale, bringing together more than 150 leading pediatric cancer researchers, clinicians and foundations to promote the exchange of information and ideas for advancing pediatric cancer research and treatment.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).
› Verified 7 days ago
| Entity Name | Midwest Ear, Nose & Throat Associates P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003871419 PECOS PAC ID: 8729990940 Enrollment ID: O20031105000117 |
News Archive
The epic of health care evolution is complex and is worth reviewing over the last five decades. Having practiced medicine in the same community in Southeast Missouri for more than 30 years, I have seen changes in health care beyond the scope of imagination (Dr. S.D. Madduri, 2/18).
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
The Translational Genomics Research Institute (TGen) will host Pediatric Cancer Translational Genomics Feb. 6-8 at the Hotel Valley Ho in Scottsdale, bringing together more than 150 leading pediatric cancer researchers, clinicians and foundations to promote the exchange of information and ideas for advancing pediatric cancer research and treatment.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Micah Marshall Likness, MD 1104 W 8th St, Yankton, SD 57078-3306 Ph: (605) 665-7841 | Dr Micah Marshall Likness, MD 2525 Fox Run Parkway, Suite 101, Yankton, SD 57078-5371 Ph: (605) 665-0062 |
News Archive
The epic of health care evolution is complex and is worth reviewing over the last five decades. Having practiced medicine in the same community in Southeast Missouri for more than 30 years, I have seen changes in health care beyond the scope of imagination (Dr. S.D. Madduri, 2/18).
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
The Translational Genomics Research Institute (TGen) will host Pediatric Cancer Translational Genomics Feb. 6-8 at the Hotel Valley Ho in Scottsdale, bringing together more than 150 leading pediatric cancer researchers, clinicians and foundations to promote the exchange of information and ideas for advancing pediatric cancer research and treatment.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).
› Verified 7 days ago
Robert Nicholas, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2525 Fox Run Pkwy Ste 101, Yankton, SD 57078 Phone: 605-665-0062 Fax: 605-665-0076 | |
Dr. David Joel Abbott, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2525 Fox Run Pkwy, Suite 101, Yankton, SD 57078 Phone: 605-665-0062 Fax: 605-665-0076 |